These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28255444)

  • 1. Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases.
    Muneoka K; Kanahara N; Kimura S
    SAGE Open Med Case Rep; 2017; 5():2050313X17692936. PubMed ID: 28255444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid efficacy of aripiprazole in the treatment of catatonic depression/catatonia with consideration of the drug's unique receptor profile: a case report.
    Sichert V; Volz HP
    Fortschr Neurol Psychiatr; 2021 Apr; 89(4):178-181. PubMed ID: 32575133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory catatonic schizophrenia with low dose aripiprazole.
    Sasaki T; Hashimoto T; Niitsu T; Kanahara N; Iyo M
    Ann Gen Psychiatry; 2012 May; 11(1):12. PubMed ID: 22553911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study.
    Kanahara N; Takase M; Sasaki T; Honma M; Fujita Y; Tadokoro S; Suzuki H; Yamanaka H; Noda S; Yanahashi S; Saiga T; Komatsu N; Simoyama T; Iyo M
    Int Clin Psychopharmacol; 2020 Nov; 35(6):338-344. PubMed ID: 32868522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report.
    Yamashita S; Miyaoka T; Nagahama M; Ieda M; Tsuchie K; Wake R; Horiguchi J
    Clin Schizophr Relat Psychoses; 2016; 10(1):37-40. PubMed ID: 24047761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case series on aripiprazole and dopamine supersensitivity psychosis.
    Russell G; Reinfeld S; Kam O; Lee G; Weiss M; Koola MM
    Int Clin Psychopharmacol; 2022 May; 37(3):122-128. PubMed ID: 35143441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catatonic Schizophrenia: Cases with Possible Genetic Predisposition.
    Tariq M; Afridi MI; Saleem D; Pirzada S
    Cureus; 2019 Apr; 11(4):e4525. PubMed ID: 31263634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aripiprazole as dopamine partial agonist model: Basic concepts and clinical impact].
    Simon N; Azorin JM
    Encephale; 2018 Dec; 44(6):558-564. PubMed ID: 30466778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
    Menard ML; Yagoubi F; Drici M; Lavrut T; Askenazy F
    Encephale; 2013 May; 39 Suppl 1():S29-35. PubMed ID: 23219595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.
    Takase M; Kanahara N; Oda Y; Kimura H; Watanabe H; Iyo M
    J Psychopharmacol; 2015 Apr; 29(4):383-9. PubMed ID: 25735995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole relieves catatonia but worsens hallucination in a patient with catatonic schizophrenia.
    Lin CH; Tsai YF; Huang WL
    Asia Pac Psychiatry; 2016 Jun; 8(2):176. PubMed ID: 27062667
    [No Abstract]   [Full Text] [Related]  

  • 13. Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report.
    Fukai M; Hirosawa T; Takahashi T; Kaneda R; Kikuchi M; Minabe Y
    Ther Adv Psychopharmacol; 2017 Mar; 7(3):113-117. PubMed ID: 28348731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.
    Chouinard G; Samaha AN; Chouinard VA; Peretti CS; Kanahara N; Takase M; Iyo M
    Psychother Psychosom; 2017; 86(4):189-219. PubMed ID: 28647739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aripiprazole induced Parkinsonism: A case report].
    Pasquier de Franclieu S; Germain C; Petitjean F
    Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Response of Long-Standing, Treatment-Resistant Non-Catatonic Mutism in Paranoid Schizophrenia with Single ECT session.
    Dar MA; Rather YH; Shah MS; Wani RA; Hussain A
    N Am J Med Sci; 2014 Nov; 6(11):591-4. PubMed ID: 25535609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged catatonic stupor successfully treated with aripiprazole in an adolescent male with schizophrenia: a case report.
    Kirino E
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):185-8. PubMed ID: 20880829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catatonic Symptoms Successfully Treated with Olanzapine in an Adolescent with Schizophrenia.
    Kufert Y; Mor M; Artunduaga JC; Coffey BJ
    J Child Adolesc Psychopharmacol; 2021 May; 31(4):327-330. PubMed ID: 34014770
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment resistant non-catatonic mutism in schizophrenia responding to a combination of continuation electroconvulsive therapy and neuroleptics.
    Grover S; Dutt A; Chakrabarty K; Kumar V
    Ind Psychiatry J; 2012 Jan; 21(1):69-71. PubMed ID: 23766583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    Mukundan A; Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD006629. PubMed ID: 21154372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.